Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Strand

Strand

Feb 08, 2018

Strand Life Sciences Completes $13M Financing Round

Private equity firm Quadria Capital led the investment round and was joined by HealthQuad Fund and Heritas Venture Fund.

Mar 14, 2016

Venaxis, Strand Terminate Merger Plans

The two companies, who announced the merger in January, said they could not complete the terms of their deal in a timely enough manner.

Feb 25, 2016

UPDATE: Strand's India Laboratory Receives CAP, NABL Accreditations

The Strand Center for Genomics and Personalized Medicine lab is now accredited in India to perform three of Strand's most popular tests. 

Jan 26, 2016

Venaxis Merges With Strand Life Sciences

Once the deal is fully concluded, Strand's shareholders will own approximately 68 percent of the new company, while Venaxis shareholders will own 32 percent.

Oct 05, 2015

Strand Aims to Push Cancer Sequencing Earlier in Patients' Disease Course

Premium

Strand provides a standard of care report that includes a handful of genes and IHC markers within eight days, and the full 152-gene report seven to 12 days later.

Jun 29, 2015

ReadSense, Strand Life Sciences Ink Genetic Diseases Diagnostics Deal

The companies anticipate launching the next-generation sequencing-based tests in Russia "in the near future."

Jun 23, 2015

Tataa Biocenter to Distribute Strand's NGS Analysis Software in Europe

Under the terms of the agreement, Tataa will distribute and support Strand's analysis software in Europe and will also use the tool in training programs.

Apr 15, 2015

Strand Life Sciences Opens Colorado CLIA Lab; Launches Tumor Sequencing Test

Premium

The StrandAdvantage test currently analyzes 48 cancer-related genes on one of the laboratory's three Illumina MiSeq instruments.

Mar 31, 2015

Strand Collaborates with MRI Global on Indian Reference Lab, CDx

The partners will integrate Strand's informatics software with MRI Global's mobile diagnostic labs and co-develop companion diagnostics.

Nov 07, 2014

Leucine Rich Bio Prepares to Launch Clinical Genome Interpretation SaaS Offering

Premium

NEW YORK (GenomeWeb) – Bangalore, India-based Leucine Rich Bio has developed and is preparing to launch a new cloud-based software-as-a-service solution dubbed CtoG to help clinical genetics laboratories identify potentially harmful mutations in data from their next-generation sequencing-based te

Pages

The Scan

And Maybe Not

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Now Onto a Hungry Caterpillar

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

This Variant Here

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

Nature Papers Present Tool for Topological Analysis of Chromosomes, Map of Genome-Lipid Associations

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.